UA106507C2 - Кон'югати димерів піроло[1,4]бензодіазепіну як протираковий засіб - Google Patents

Кон'югати димерів піроло[1,4]бензодіазепіну як протираковий засіб

Info

Publication number
UA106507C2
UA106507C2 UAA201203443A UAA201203443A UA106507C2 UA 106507 C2 UA106507 C2 UA 106507C2 UA A201203443 A UAA201203443 A UA A201203443A UA A201203443 A UAA201203443 A UA A201203443A UA 106507 C2 UA106507 C2 UA 106507C2
Authority
UA
Ukraine
Prior art keywords
pyrrolo
conjugates
anticancer agent
benzodiazepine dimers
benzodiazepine
Prior art date
Application number
UAA201203443A
Other languages
English (en)
Russian (ru)
Inventor
Алєн Коммерсон
Лоранс Гозі-Лазо
Original Assignee
Санофі
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофі filed Critical Санофі
Publication of UA106507C2 publication Critical patent/UA106507C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/06—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 containing at least one condensed beta-lactam ring system, provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00, e.g. a penem or a cepham system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Винахід стосується нових кон'югатів димерів піроло[1,4]бензодіазепіну (І), які можуть бути використані як протиракові засоби. EMBED ISISServer (I)
UAA201203443A 2009-08-25 2010-08-12 Кон'югати димерів піроло[1,4]бензодіазепіну як протираковий засіб UA106507C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0904043A FR2949469A1 (fr) 2009-08-25 2009-08-25 Derives anticancereux, leur preparation et leur application en therapeutique
FR0904368A FR2949470B1 (fr) 2009-08-25 2009-09-11 Derives anticancereux, leur preparation et leur application therapeutique
PCT/FR2010/051709 WO2011023883A1 (fr) 2009-08-25 2010-08-12 Conjugues de dimeres de pyrrolo [1, 4 ] benzodiazepine en tant qu' anticancereux

Publications (1)

Publication Number Publication Date
UA106507C2 true UA106507C2 (uk) 2014-09-10

Family

ID=41720559

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201203443A UA106507C2 (uk) 2009-08-25 2010-08-12 Кон'югати димерів піроло[1,4]бензодіазепіну як протираковий засіб

Country Status (33)

Country Link
US (2) US8481042B2 (uk)
EP (1) EP2470547B1 (uk)
JP (1) JP5889189B2 (uk)
KR (1) KR20130026405A (uk)
CN (1) CN102753559B (uk)
AR (1) AR078143A1 (uk)
AU (1) AU2010288382B2 (uk)
BR (1) BR112012004146A2 (uk)
CA (1) CA2772102C (uk)
CL (2) CL2012000489A1 (uk)
CO (1) CO6612210A2 (uk)
CR (1) CR20120085A (uk)
DO (1) DOP2012000038A (uk)
EA (1) EA026488B1 (uk)
EC (1) ECSP12011688A (uk)
ES (1) ES2484690T3 (uk)
FR (2) FR2949469A1 (uk)
GT (1) GT201200046A (uk)
HN (1) HN2012000437A (uk)
IL (1) IL218262A0 (uk)
MA (1) MA33600B1 (uk)
MX (1) MX2012002434A (uk)
MY (1) MY157469A (uk)
NI (1) NI201200031A (uk)
NZ (1) NZ598401A (uk)
PE (1) PE20120992A1 (uk)
SG (1) SG178537A1 (uk)
TN (1) TN2012000053A1 (uk)
TW (1) TWI477275B (uk)
UA (1) UA106507C2 (uk)
UY (1) UY32854A (uk)
WO (1) WO2011023883A1 (uk)
ZA (1) ZA201201397B (uk)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2789622B1 (en) 2010-04-15 2017-03-01 MedImmune Limited Pyrrolobenzodiazepines used to treat proliferative diseases
EA024118B1 (ru) 2010-04-15 2016-08-31 Сиэтл Дженетикс, Инк. Конъюгаты пирролбензодиазепина направленного действия
KR101860174B1 (ko) 2011-09-20 2018-05-21 메디뮨 리미티드 표적 접합체 내의 내포를 위한 비대칭 이량체 pbd 화합물로서 피롤로벤조디아제핀
EP2751111B1 (en) 2011-10-14 2017-04-26 MedImmune Limited Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases
KR101961976B1 (ko) 2011-10-14 2019-03-25 시애틀 지네틱스, 인크. 피롤로벤조디아제핀 및 표적 접합체
ES2945932T3 (es) 2011-10-14 2023-07-10 Seagen Inc Pirrolobenzodiazepinas y conjugados dirigidos
AU2012322932B2 (en) 2011-10-14 2016-11-10 Medimmune Limited Pyrrolobenzodiazepines
CA2858806A1 (en) 2011-12-23 2013-06-27 Innate Pharma Enzymatic conjugation of polypeptides
US9504756B2 (en) 2012-05-15 2016-11-29 Seattle Genetics, Inc. Self-stabilizing linker conjugates
MX368678B (es) 2012-05-15 2019-10-11 Seattle Genetics Inc Conjugados enlazadores auto-estabilizantes.
WO2014009426A2 (en) 2012-07-13 2014-01-16 Innate Pharma Screening of conjugated antibodies
KR101995620B1 (ko) 2012-10-12 2019-07-03 에이디씨 테라퓨틱스 에스에이 피롤로벤조디아제핀-항체 컨주게이트
NZ707534A (en) 2012-10-12 2018-08-31 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
WO2014057072A1 (en) 2012-10-12 2014-04-17 Spirogen Sàrl Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
NZ707490A (en) 2012-10-12 2018-09-28 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
CA3060520C (en) 2012-10-12 2022-05-17 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
CA2887894C (en) 2012-10-12 2019-10-29 Adc Therapeutics Sarl Pyrrolobenzodiazepine - anti-psma antibody conjugates
LT2839860T (lt) 2012-10-12 2019-07-10 Medimmune Limited Pirolobenzodiazepinai ir jų konjugatai
US10736903B2 (en) 2012-10-12 2020-08-11 Medimmune Limited Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
US10695433B2 (en) 2012-10-12 2020-06-30 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
EP3564259A3 (en) 2012-11-09 2020-02-12 Innate Pharma Recognition tags for tgase-mediated conjugation
TWI680766B (zh) * 2013-03-13 2020-01-01 英商梅迪繆思有限公司 吡咯并苯并二氮呯及其共軛物
ES2843786T3 (es) 2013-03-13 2021-07-20 Seagen Inc Filtración con carbono activado para la purificación de ADC de benzodiazepina
JP6340019B2 (ja) 2013-03-13 2018-06-06 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ ピロロベンゾジアゼピン及びそのコンジュゲート
EP2968582B1 (en) 2013-03-15 2020-07-01 Innate Pharma Solid phase tgase-mediated conjugation of antibodies
EP3010547B1 (en) 2013-06-20 2021-04-21 Innate Pharma Enzymatic conjugation of polypeptides
EP3010548A1 (en) 2013-06-21 2016-04-27 Innate Pharma Enzymatic conjugation of polypeptides
EP3054985B1 (en) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
WO2015052532A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
SG11201600954XA (en) 2013-10-15 2016-03-30 Seattle Genetics Inc Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
ES2931927T3 (es) 2013-12-19 2023-01-04 Seagen Inc Enlazadores a base de carbamato de metileno para uso con los conjugados focalizados
CA3211226A1 (en) 2014-02-11 2015-08-20 Seagen Inc. Selective reduction of proteins
WO2016008112A1 (en) 2014-07-16 2016-01-21 Medshine Discovery Inc. Linkers and application towards adc thereof
CN114106185A (zh) 2014-09-12 2022-03-01 基因泰克公司 抗her2抗体和免疫缀合物
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
WO2016044396A1 (en) 2014-09-17 2016-03-24 Genentech, Inc. Immunoconjugates comprising anti-her2 antibodies and pyrrolobenzodiazepines
CN107148285B (zh) 2014-11-25 2022-01-04 Adc治疗股份有限公司 吡咯并苯并二氮杂䓬-抗体缀合物
KR20170102980A (ko) 2015-01-14 2017-09-12 브리스톨-마이어스 스큅 컴퍼니 벤조디아제핀 이량체, 그의 접합체, 및 제조 및 사용 방법
JP6676058B2 (ja) 2015-01-14 2020-04-08 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ ヘテロアリーレン架橋したベンゾジアゼピン二量体、そのコンジュゲート、ならびに製造および使用方法
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
US9688694B2 (en) 2015-06-23 2017-06-27 Bristol-Myers Squibb Company Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses
MA43345A (fr) 2015-10-02 2018-08-08 Hoffmann La Roche Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
EA201892040A1 (ru) 2016-03-25 2019-04-30 Сиэтл Дженетикс, Инк. Способ получения пегилированных соединений лекарственный препарат - линкер и их промежуточных соединений
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
KR20240010534A (ko) 2016-08-09 2024-01-23 씨젠 인크. 개선된 물리화학적 특성을 갖는 자기 안정화 링커를 구비한 약물 접합체
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
JP7244987B2 (ja) 2016-12-14 2023-03-23 シージェン インコーポレイテッド 多剤抗体薬物コンジュゲート
CN110300765B (zh) 2017-01-24 2024-08-23 依奈特制药公司 Nkp46结合剂
WO2018141959A1 (en) 2017-02-06 2018-08-09 Innate Pharma Immunomodulatory antibody drug conjugates binding to a human mica polypeptide
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
PT3544636T (pt) 2017-02-08 2021-05-04 Medimmune Ltd Conjugados de anticorpos-pirrolobenzodiazepinas
WO2018175994A1 (en) 2017-03-24 2018-09-27 Seattle Genetics, Inc. Process for the preparation of glucuronide drug-linkers and intermediates thereof
HUE059828T2 (hu) 2017-04-18 2023-01-28 Medimmune Ltd Pirrolobenzodiazepin konjugátumok
CA3057748A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
BR112019026564A2 (pt) 2017-06-14 2020-06-30 Adc Therapeutics Sa regimes de dosagem para a administração de um adc anti-cd19
SI3668874T1 (sl) 2017-08-18 2022-04-29 Medimmune Limited Pirolobenzodiazepinski konjugati
WO2019065964A1 (ja) 2017-09-29 2019-04-04 第一三共株式会社 抗体－ピロロベンゾジアゼピン誘導体コンジュゲート
WO2019092148A1 (en) 2017-11-10 2019-05-16 Innate Pharma Antibodies with functionalized glutamine residues
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) * 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN114450324B (zh) 2019-09-26 2024-02-27 日油株式会社 具有肽连接子的异双官能单分散聚乙二醇
CN115955980A (zh) 2020-04-10 2023-04-11 思进公司 电荷可变接头
AU2021387795A1 (en) 2020-11-25 2023-06-01 Innate Pharma Treatment of cancer
KR20230158005A (ko) 2021-03-18 2023-11-17 씨젠 인크. 생물학적 활성 화합물의 내재화된 접합체로부터의 선택적 약물 방출
KR20230158006A (ko) 2021-03-18 2023-11-17 씨젠 인크. 생물학적 활성 화합물의 내재화된 접합체로부터의 선택적 약물 방출
WO2023227660A1 (en) 2022-05-25 2023-11-30 Innate Pharma Nectin-4 binding agents
WO2024129756A1 (en) 2022-12-13 2024-06-20 Seagen Inc. Site-specific engineered cysteine antibody drug conjugates
CN117875311B (zh) * 2024-01-11 2024-06-21 北京领初医药科技有限公司 一种缩略语句匹配方法、装置及存储介质

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1516743A (fr) 1966-04-01 1968-02-05 Rhone Poulenc Sa Nouvel antibiotique et son procédé de préparation par culture de streptomyces croceus
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
GB9205051D0 (en) * 1992-03-09 1992-04-22 Cancer Res Campaign Tech Pyrrolobenzodiazepine derivatives,their preparation,and compositions containing them
KR19990029749A (ko) * 1997-09-17 1999-04-26 미우라 아끼라 2가 반응성 수용성 고분자 유도체 및 이들을 함유하는 복합체
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
DE69925133T2 (de) * 1998-08-27 2006-01-19 Spirogen Ltd., Ryde Pyrrolobenzodiazepine
JP3996897B2 (ja) * 2001-06-08 2007-10-24 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス ソマトスタチン−ドーパミンキメラ類似体
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US7230101B1 (en) 2002-08-28 2007-06-12 Gpc Biotech, Inc. Synthesis of methotrexate-containing heterodimeric molecules
EA010570B1 (ru) 2002-11-07 2008-10-30 Иммьюноджен, Инк. Антитело к cd33 и способы его применения
WO2004103272A2 (en) 2003-05-20 2004-12-02 Immunogen, Inc. Improved cytotoxic agents comprising new maytansinoids
ATE496944T1 (de) 2003-07-21 2011-02-15 Immunogen Inc Ca6-antigenspezifisches zytotoxisches konjugat und verfahren zu dessen anwendung
WO2005040170A2 (en) 2003-10-22 2005-05-06 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
US7528126B2 (en) 2004-03-09 2009-05-05 Spirogen Limited Pyrrolobenzodiazepines
EP1669358A1 (en) 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
US7385028B2 (en) 2004-12-22 2008-06-10 Ambrx, Inc Derivatization of non-natural amino acids and polypeptides
AU2006311485B2 (en) * 2005-11-08 2012-09-27 Immunogen, Inc. Processes for preparation of maytansinol
RS52060B (en) * 2006-01-25 2012-04-30 Sanofi CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES
EP1832577A1 (en) 2006-03-07 2007-09-12 Sanofi-Aventis Improved prodrugs of CC-1065 analogs
EP2010475A2 (en) 2006-04-27 2009-01-07 Intezyne Technologies Incorporated Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
EP1864682A1 (en) 2006-06-09 2007-12-12 Sanofi-Aventis Leptomycin derivatives
ES2673822T3 (es) * 2006-07-18 2018-06-25 Sanofi Anticuerpo antagonista contra EphA2 para el tratamiento de cáncer
EP1914242A1 (en) 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
PT2019104E (pt) * 2007-07-19 2013-12-03 Sanofi Sa Agentes citotóxicos compreendendo novos derivados de tomaimicina e sua utilização terapêutica
EP2185188B1 (en) 2007-08-22 2014-08-06 Medarex, L.L.C. Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
SG189817A1 (en) * 2008-04-30 2013-05-31 Immunogen Inc Potent conjugates and hydrophilic linkers
MX2011008328A (es) * 2009-02-05 2011-11-04 Immunogen Inc Derivados novedosos de benzodiacepina.
AR078471A1 (es) * 2009-10-02 2011-11-09 Sanofi Aventis COMPUESTOS MAITANSINOIDES Y EL USO DE ESTOS PARA PREPARAR CONJUGADOS CON UN ANTICUERPO LOS CUALES SE UTILIZAN COMO AGENTES ANTICANCERIGENOS Y EL PROCEDIMIENTO DE PREPARACIoN DE ESTOS CONJUGADOS
FR2963007B1 (fr) * 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique

Also Published As

Publication number Publication date
IL218262A0 (en) 2012-04-30
EA026488B1 (ru) 2017-04-28
MA33600B1 (fr) 2012-09-01
US8481042B2 (en) 2013-07-09
WO2011023883A1 (fr) 2011-03-03
GT201200046A (es) 2014-09-26
ES2484690T3 (es) 2014-08-12
BR112012004146A2 (pt) 2017-05-30
JP2013503143A (ja) 2013-01-31
KR20130026405A (ko) 2013-03-13
MY157469A (en) 2016-06-15
ECSP12011688A (es) 2012-03-30
ZA201201397B (en) 2013-05-29
NZ598401A (en) 2014-03-28
CN102753559B (zh) 2015-11-25
TW201119657A (en) 2011-06-16
FR2949470B1 (fr) 2011-11-04
DOP2012000038A (es) 2012-06-15
CA2772102C (fr) 2018-09-04
CO6612210A2 (es) 2013-02-01
CR20120085A (es) 2012-06-01
AU2010288382B2 (en) 2015-10-22
CA2772102A1 (fr) 2011-03-03
EP2470547B1 (fr) 2014-05-14
SG178537A1 (en) 2012-03-29
JP5889189B2 (ja) 2016-03-22
FR2949469A1 (fr) 2011-03-04
NI201200031A (es) 2013-09-18
AU2010288382A1 (en) 2012-03-15
US20140155590A1 (en) 2014-06-05
PE20120992A1 (es) 2012-08-22
US20120244172A1 (en) 2012-09-27
FR2949470A1 (fr) 2011-03-04
MX2012002434A (es) 2012-07-20
CN102753559A (zh) 2012-10-24
EP2470547A1 (fr) 2012-07-04
AR078143A1 (es) 2011-10-19
HN2012000437A (es) 2015-03-02
EA201270308A1 (ru) 2013-01-30
TN2012000053A1 (fr) 2013-09-19
UY32854A (es) 2011-03-31
TWI477275B (zh) 2015-03-21
CL2013001609A1 (es) 2013-11-04
CL2012000489A1 (es) 2012-08-03

Similar Documents

Publication Publication Date Title
UA106507C2 (uk) Кон'югати димерів піроло[1,4]бензодіазепіну як протираковий засіб
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
MY160456A (en) Benzodiazepine bromodomain inhibitor
IN2012DN02984A (uk)
EP2477985A4 (en) CANCER TREATMENT
MY159197A (en) Anticancer derivatives, preparation thereof and therapeutic use thereof
MX351810B (es) Metodos y composiciones que se relacionan con oligosacaridos sinteticos de beta-1, 6 glucosamina.
GB0613208D0 (en) Compounds
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
TW200942530A (en) Pyridine compounds
MX2009007336A (es) Indazoles substituidos con 5-furopiridinona.
MX2011011730A (es) Micelas polimericas que contienen sn-38 para el tratamiento de cancer.
MY149433A (en) Nutritional compositions containing punicalagins
EP2576575A4 (en) PROSTAGLANDIN-BISPHOSPHONATE CONJUGATE COMPOUNDS, THEIR METHODS OF MANUFACTURE AND USES THEREOF
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
GB2469980A8 (en) Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof.
UA109677C2 (uk) СПОЛУКИ ОКСАЗОЛ[5,4-b]ПІРИДИН-5-ІЛУ ТА ЇХ ЗАСТОСУВАННЯ У ЛІКУВАННІ РАКУ
MX2009003196A (es) Proceso para la preparacion de y-butirolactonas.
UA35660U (en) Use of antihomotoxic preparations as cytoprotectors
UA87793C2 (uk) 3-аміно-1,1,1-трифторопропан-2-сульфонат натрію
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
UA41922U (uk) Застосування альтану як речовини з протипроменевими властивостями
UA42812U (uk) Застосування мазі тіотриазоліну як речовини з фотопротекторними властивостями
UA95349C2 (uk) Застосування поліфенольного комплексу з суцвіть липи як противиразкового засобу
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer